{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:10:59Z","timestamp":1787163059789,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Neurosciences Research Program"},{"name":"IMIM-Hospital del Mar, Barcelona, Spain"},{"name":"DIUE de la Generalitat de Catalunya"},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Intramural Research Program"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ejphar.2011.10.033","type":"journal-article","created":{"date-parts":[[2011,11,3]],"date-time":"2011-11-03T16:04:18Z","timestamp":1320336258000},"page":"337-344","source":"Crossref","is-referenced-by-count":24,"title":["Effects of MDMA and related analogs on plasma 5-HT: Relevance to 5-HT transporters in blood and brain"],"prefix":"10.1016","volume":"674","author":[{"given":"Samanta","family":"Yubero-Lahoz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Mario A.","family":"Ayestas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Partilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.10.033_bb0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00213-006-0322-6","article-title":"3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings","volume":"189","author":"Baumann","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuroscience.2008.01.007","article-title":"Tolerance to 3,4-methylenedioxymethamphetamine (MDMA) in rats exposed to single high-dose binges","volume":"152","author":"Baumann","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0015","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1124\/dmd.109.028506","article-title":"Effects of dose and route of administration on pharmacokinetics of (+\/\u2212)-3,4-methylenedioxymethamphetamine in the rat","volume":"37","author":"Baumann","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.130.6.1657","article-title":"Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?","volume":"130","author":"Chin","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0025","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.bjp.0701325","article-title":"Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine","volume":"121","author":"Crespi","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjp.2008.241","article-title":"Pulmonary hypertension: therapeutic targets within the serotonin system","volume":"155","author":"Dempsie","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0040","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/syn.20443","article-title":"Neuroimaging of the serotonin reuptake site requires high-affinity ligands","volume":"61","author":"Elkving","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0706071","article-title":"A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine on brain monoamine levels after i.p. or striatal administration in mice","volume":"144","author":"Escobedo","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0050","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1124\/jpet.109.150573","article-title":"Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations","volume":"329","author":"Fantegrossi","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bjp.0704502","article-title":"The effect of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) and its metabolites on neurohypophysial hormone release from isolated rat hypothalamus","volume":"135","author":"Forsling","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-007-1027-1","article-title":"The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity","volume":"197","author":"Goni-Allo","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1471-4159.1996.66010243.x","article-title":"Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin\u2013dopamine interactions","volume":"66","author":"Gudelsky","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0070","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0006-3223(99)00171-7","article-title":"A relationship between serotonin transporter genotype, in vivo protein expression and alcohol neurotoxicity","volume":"47","author":"Heinz","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension","volume":"99","author":"Herve","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0080","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2174\/156802610793176792","article-title":"Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination?","volume":"10","author":"Huang","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/FTD.0b013e3181684fa0","article-title":"Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults","volume":"30","author":"Kolbrich","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hup.348","article-title":"Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies","volume":"16","author":"Liechti","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/bmj.300.6719.230","article-title":"Analysis of serial measurements in medical research","volume":"333","author":"Matthews","year":"1990","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/mi.10.4.6","article-title":"Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels","volume":"10","author":"Mercado","year":"2010","journal-title":"Mol. Interv."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1681.2006.04410.x","article-title":"5-Hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT)","volume":"33","author":"Ni","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0110","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/00004583-199911000-00014","article-title":"Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents","volume":"38","author":"Nobile","year":"1999","journal-title":"J. Am. Acad. Child Adolesc."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hup.351","article-title":"Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research","volume":"16","author":"Parrott","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0120","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1073\/pnas.90.6.2542","article-title":"Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization","volume":"90","author":"Ramamoorthy","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-005-2178-6","article-title":"Serotonin transport kinetics correlated between human platelets and brain synaptosomes","volume":"180","author":"Rausch","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-009-8053-4","article-title":"A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters","volume":"39","author":"Robertson","year":"2009","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0135","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1378\/chest.07-0235","article-title":"Methamphetamine and idiopathic pulmonary arterial hypertension: role of the serotonin transporter","volume":"132","author":"Rothman","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0140","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","article-title":"Aminorex, fenfluramine and chlorphentermine are serotonin transporter substrates. Implications for pulmonary hypertension","volume":"100","author":"Rothman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1124\/jpet.103.053975","article-title":"In vitro characterization of ephedrine stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates","volume":"307","author":"Rothman","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0155","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1073\/pnas.89.5.1817","article-title":"The molecular mechanism of \u201cecstasy\u201d [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release","volume":"89","author":"Rudnick","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0160","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0026-895X(25)13357-9","article-title":"Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters","volume":"44","author":"Schuldiner","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1471-4159.2009.06474.x","article-title":"The reverse operation of Na+\/Cl\u2212 coupled neurotransmitter transporters: why amphetamines take two to tango","volume":"112","author":"Sitte","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neulet.2006.06.004","article-title":"Brain and platelet serotonin transporter in humans: correlation between [123I]-ADAM SPECT and serotonergic measurements in platelets","volume":"406","author":"Uebelhack","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.10.033_bb0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.thromres.2007.01.007","article-title":"Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion and thromboxane A2 formation","volume":"120","author":"Viisoreanu","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2011.10.033_bb0185","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1124\/jpet.106.101618","article-title":"Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease","volume":"318","author":"Zolkowska","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911014014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911014014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:39:25Z","timestamp":1741880365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911014014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":37,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0014299911014014"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.10.033","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}